{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T03:34:11Z","timestamp":1770780851683,"version":"3.50.0"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1001\/jamaophthalmol.2018.5413","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T21:06:18Z","timestamp":1542056778000},"page":"232","source":"Crossref","is-referenced-by-count":8,"title":["Association of Blepharitis and Ectropion With Tumor Necrosis Factor \u03b1 Inhibitor Treatment in Crohn Disease"],"prefix":"10.1001","volume":"137","author":[{"given":"Honeylen Maryl Tiu","family":"Teo","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"de S\u00e1 Freire","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Demirci","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"6","key":"elo180012r1","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.5114\/aoms.2014.47827","article-title":"Tumor necrosis factor inhibitors: state of knowledge.","volume":"10","author":"Lis","year":"2014","journal-title":"Arch Med Sci"},{"issue":"1","key":"elo180012r3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/IOP.0b013e31802d97f0","article-title":"Newly recognized ocular side effects of erlotinib.","volume":"23","author":"Methvin","year":"2007","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"elo180012r4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ajoc.2017.06.017","article-title":"Cicatricial ectropion in a patient treated with dupilumab.","volume":"7","author":"Barnes","year":"2017","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"1","key":"elo180012r5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.autrev.2013.06.005","article-title":"Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-a agents.","volume":"13","author":"Fiorino","year":"2014","journal-title":"Autoimmun Rev"},{"key":"elo180012r2","unstructured":"IervolinoA. EvaluatePharma world preview 2017, outlook to 2022 10th Ed.  http:\/\/www.evaluategroup.com\/public\/reports\/EvaluatePharma-World-Preview-2017.aspx. Published June 2017. Accessed February 3, 2018."}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaophthalmology\/article-pdf\/137\/2\/232\/17294596\/jamaophthalmology_teo_2018_lo_180012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T16:58:30Z","timestamp":1550163510000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.5413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.5413","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}